Alvotech Increases Own Shares with $15.98 Issuance Price to Grow Share Capital
Alvotech, a leading biotech company specializing in biosimilar medicines, has announced a significant increase in its own shares.The company has issued thirteen million ordinary shares to its subsidiary, Alvotech Manco ehf. increasing its share capital by $130,000.This move comes as Alvotech aims to expand its reach and presence in the global market for biosimilar medicines.
The newly issued shares, priced at $15.98 per share, have been subscribed to by the subsidiary.These shares are held as treasury shares, meaning they do not carry voting rights or dividend en
Comments